These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 18624801

  • 1. Difference in triptan effect in patients with migraine and early allodynia.
    Lampl C, Huber G, Haas S, Rittberger E, Diener HC.
    Cephalalgia; 2008 Oct; 28(10):1031-8. PubMed ID: 18624801
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M.
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [Abstract] [Full Text] [Related]

  • 6. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.
    Goadsby PJ, Zanchin G, Geraud G, de Klippel N, Diaz-Insa S, Gobel H, Cunha L, Ivanoff N, Falques M, Fortea J.
    Cephalalgia; 2008 Apr; 28(4):383-91. PubMed ID: 18294251
    [Abstract] [Full Text] [Related]

  • 7. Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet.
    Dowson AJ, Charlesworth BR.
    Int J Clin Pract; 2003 Sep; 57(7):573-6. PubMed ID: 14529055
    [Abstract] [Full Text] [Related]

  • 8. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M, Marbury T, O'Neill C, Siegel S, Du W, Sebree T.
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).
    Winner P, Farkas V, Štillová H, Woodruff B, Liss C, Lillieborg S, Raines S, TEENZ Study Group.
    Headache; 2016 Jul; 56(7):1107-19. PubMed ID: 27329280
    [Abstract] [Full Text] [Related]

  • 10. Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.
    Sheftell FD, Feleppa M, Tepper SJ, Volcy M, Rapoport AM, Bigal ME.
    Headache; 2004 Jul; 44(7):661-8. PubMed ID: 15209687
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Zolmitriptan (Zomig).
    Rapoport AM, Bigal ME, Tepper SJ, Sheftell FD.
    Expert Rev Neurother; 2004 Jan; 4(1):33-41. PubMed ID: 15853613
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: results of a postmarketing surveillance study.
    Diener HC, Evers S.
    Clin Drug Investig; 2007 Jan; 27(1):59-66. PubMed ID: 17177580
    [Abstract] [Full Text] [Related]

  • 15. Differences of anti-nociceptive mechanisms of migraine drugs on the trigeminal pain processing during and outside acute migraine attacks.
    Katsarava Z, Limmroth V, Baykal O, Akguen D, Diener HC, Kaube H.
    Cephalalgia; 2004 Aug; 24(8):657-62. PubMed ID: 15265054
    [Abstract] [Full Text] [Related]

  • 16. Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials.
    Dahlöf CG.
    Cephalalgia; 2006 Feb; 26(2):98-106. PubMed ID: 16426262
    [Abstract] [Full Text] [Related]

  • 17. Sumatriptan (5-HT1B/1D-agonist) causes a transient allodynia.
    Linde M, Elam M, Lundblad L, Olausson H, Dahlöf CG.
    Cephalalgia; 2004 Dec; 24(12):1057-66. PubMed ID: 15566420
    [Abstract] [Full Text] [Related]

  • 18. Clarification of developing and established clinical allodynia and pain-free outcomes.
    Landy SH, McGinnis JE, McDonald SA.
    Headache; 2007 Feb; 47(2):247-52. PubMed ID: 17300364
    [Abstract] [Full Text] [Related]

  • 19. Patient preference for triptan formulations: a prospective study with zolmitriptan.
    Dowson A, Bundy M, Salt R, Kilminster S.
    Headache; 2007 Sep; 47(8):1144-51. PubMed ID: 17883519
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.